BANK VONTOBEL/CALL/MEDTRONIC/98/0.1/20.09.24 Share Price

Warrant

DE000VM8D460

Market Closed - Boerse Frankfurt Warrants 11:24:45 04/07/2024 pm IST
0.001 EUR -50.00% Intraday chart for BANK VONTOBEL/CALL/MEDTRONIC/98/0.1/20.09.24
Current month-50.00%
1 month-93.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
04/24/04 0.001 -50.00%
03/24/03 0.002 0.00%
02/24/02 0.002 0.00%
01/24/01 0.002 0.00%
28/24/28 0.002 -71.43%

Real-time Boerse Frankfurt Warrants

Last update July 04, 2024 at 11:24 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer Vontobel Vontobel
WKN VM8D46
ISINDE000VM8D460
Date issued 11/01/2024
Strike 98 $
Maturity 20/09/2024 (78 Days)
Parity 10 : 1
Emission price 0.25
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.26
Lowest since issue 0.001
Delta0.03x
Omega 22.06
Premium27.15x
Gearing649.48x
Moneyness 0.7874
Difference Strike 20.83 $
Difference Strike %+21.26%
Spread 0.02
Spread %95.24%
Theoretical value 0.0110
Implied Volatility 26.09 %
Total Loss Probability 97.43 %
Intrinsic value 0.000000
Present value 0.0110
Break even 98.12 €
Theta-0x
Vega0x
Rho0x

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
77.17 USD
Average target price
94.02 USD
Spread / Average Target
+21.84%
Consensus